Testosterone benzoate
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | Testosterone 17β-benzoate; Androst-4-en-17β-ol-3-one 17β-benzoate |
| Routes of administration |
Intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.016.575 |
| Chemical and physical data | |
| Formula | C26H32O3 |
| Molar mass | 392.539 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Testosterone benzoate, or testosterone 17β-benzoate, also known as androst-4-en-17β-ol-3-one 17β-benzoate, is a synthetic, injected anabolic–androgenic steroid (AAS) and an androgen ester – specifically, the benzoate C17β ester of testosterone – which was never marketed. It is a prodrug of testosterone and, when administered via intramuscular injection, is associated with a long-lasting depot effect and extended duration of action. The drug was first described in 1936 and was the first androgen ester and ester of testosterone to be synthesized.